Boasso A
Scientifica (Cairo). 2014; 2013:580968.
PMID: 24455433
PMC: 3885208.
DOI: 10.1155/2013/580968.
Wang J
Chin J Integr Med. 2013; 20(2):83-7.
PMID: 24352683
DOI: 10.1007/s11655-013-1571-y.
Tel J, Anguille S, Waterborg C, Smits E, Figdor C, de Vries I
Trends Immunol. 2013; 35(1):38-46.
PMID: 24262387
PMC: 7106406.
DOI: 10.1016/j.it.2013.10.007.
Tavano B, Galao R, Graham D, Neil S, Aquino V, Fuchs D
J Immunol. 2013; 190(6):2622-30.
PMID: 23401591
PMC: 3672947.
DOI: 10.4049/jimmunol.1202391.
Bian T, Gibbs J, Orvell C, Imani F
PLoS One. 2012; 7(5):e38052.
PMID: 22662266
PMC: 3360651.
DOI: 10.1371/journal.pone.0038052.
The type I interferon response during viral infections: a "SWOT" analysis.
Gaajetaan G, Bruggeman C, Stassen F
Rev Med Virol. 2011; 22(2):122-37.
PMID: 21971992
PMC: 7169250.
DOI: 10.1002/rmv.713.
Overactivation of plasmacytoid dendritic cells inhibits antiviral T-cell responses: a model for HIV immunopathogenesis.
Boasso A, Royle C, Doumazos S, Aquino V, Biasin M, Piacentini L
Blood. 2011; 118(19):5152-62.
PMID: 21931112
PMC: 3217402.
DOI: 10.1182/blood-2011-03-344218.
Identification and characterization of the interferon-beta-mediated p53 signal pathway in human peripheral blood mononuclear cells.
Zhang F, Sriram S
Immunology. 2009; 128(1 Suppl):e905-18.
PMID: 19740351
PMC: 2753925.
DOI: 10.1111/j.1365-2567.2009.03104.x.
Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it?.
Boasso A, Shearer G, Chougnet C
J Intern Med. 2008; 265(1):78-96.
PMID: 19093962
PMC: 2903738.
DOI: 10.1111/j.1365-2796.2008.02043.x.
PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes.
Boasso A, Hardy A, Landay A, Martinson J, Anderson S, Dolan M
Clin Immunol. 2008; 129(1):132-44.
PMID: 18650129
PMC: 2771672.
DOI: 10.1016/j.clim.2008.05.009.
Combination therapy with PEG-IFN-alpha and 5-FU inhibits HepG2 tumour cell growth in nude mice by apoptosis of p53.
Hagiwara S, Kudo M, Nakatani T, Sakaguchi Y, Nagashima M, Fukuta N
Br J Cancer. 2007; 97(11):1532-7.
PMID: 17971768
PMC: 2360253.
DOI: 10.1038/sj.bjc.6604058.
HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-alpha.
Hardy A, Graham D, Shearer G, Herbeuval J
Proc Natl Acad Sci U S A. 2007; 104(44):17453-8.
PMID: 17956986
PMC: 2077277.
DOI: 10.1073/pnas.0707244104.
Chronic innate immune activation as a cause of HIV-1 immunopathogenesis.
Boasso A, Shearer G
Clin Immunol. 2007; 126(3):235-42.
PMID: 17916442
PMC: 2275778.
DOI: 10.1016/j.clim.2007.08.015.
HIV-1 immunopathogenesis: how good interferon turns bad.
Herbeuval J, Shearer G
Clin Immunol. 2006; 123(2):121-8.
PMID: 17112786
PMC: 1930161.
DOI: 10.1016/j.clim.2006.09.016.
CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis.
Herbeuval J, Grivel J, Boasso A, Hardy A, Chougnet C, Dolan M
Blood. 2005; 106(10):3524-31.
PMID: 16046522
PMC: 1895067.
DOI: 10.1182/blood-2005-03-1243.
Influenza virus infection increases p53 activity: role of p53 in cell death and viral replication.
Turpin E, Luke K, Jones J, Tumpey T, Konan K, Schultz-Cherry S
J Virol. 2005; 79(14):8802-11.
PMID: 15994774
PMC: 1168730.
DOI: 10.1128/JVI.79.14.8802-8811.2005.
